{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:33:05Z","timestamp":1765557185352,"version":"3.48.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"DOI":"10.7759\/cureus.99054","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:21:03Z","timestamp":1765556463000},"source":"Crossref","is-referenced-by-count":0,"title":["Linear IgA Bullous Dermatosis in an Elderly Patient Following Meloxicam and Candesartan Use: A Case Report"],"prefix":"10.7759","author":[{"given":"Shatha","family":"Albyali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Alhedaithi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renad","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinad","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alhumidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Alkhamees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1089-2","article-title":"Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients","volume":"14","author":"Genovese G","year":"2019","unstructured":"Genovese G, Venegoni L, Fanoni D, Muratori S, Berti E, Marzano AV. Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients. Orphanet J Rare Dis. 2019, 14:115. 10.1186\/s13023-019-1089-2","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70015-X","article-title":"Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature","volume":"30","author":"Kuechle MK","year":"1994","unstructured":"Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol. 1994, 30:187-92. 10.1016\/S0190-9622(94)70015-X","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer J","year":"2019","unstructured":"Lammer J, Hein R, Roenneberg S, Biedermann T, Volz T. Drug-induced linear IgA bullous dermatosis: a case report and review of the literature. Acta Derm Venereol. 2019, 99:508-15. 10.2340\/00015555-3154","journal-title":"Acta Derm Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20187304","article-title":"Adult linear IgA bullous dermatosis: report of three cases","volume":"93","author":"Machado TY","year":"2018","unstructured":"Machado TY, Enokihara MM, Iida TM, Porro AM. Adult linear IgA bullous dermatosis: report of three cases. An Bras Dermatol. 2018, 93:435-7. 10.1590\/abd1806-4841.20187304","journal-title":"An Bras Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02553.x","article-title":"Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis","volume":"22","author":"Sobjanek M","year":"2008","unstructured":"Sobjanek M, Sokolowska-Wojdylo M, Sztaba-Kania M, Bara\u00f1ska-Rybak W, Maciejewska A, Wlodarkiewicz A. Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol. 2008, 22:1131. 10.1111\/j.1468-3083.2007.02553.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2008.00561.x","article-title":"Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan","volume":"35","author":"Horiguchi Y","year":"2008","unstructured":"Horiguchi Y, Ikoma A, Sakai R, Masatsugu A, Ohta M, Hashimoto T. Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan. J Dermatol. 2008, 35:737-43. 10.1111\/j.1346-8138.2008.00561.x","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01649.x","article-title":"Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"29","author":"Waldman MA","year":"2004","unstructured":"Waldman MA, Black DR, Callen JP. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol. 2004, 29:633-6. 10.1111\/j.1365-2230.2004.01649.x","journal-title":"Clin Exp Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.116","article-title":"Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis","volume":"48","author":"Dellavalle RP","year":"2003","unstructured":"Dellavalle RP, Burch JM, Tayal S, Golitz LE, Fitzpatrick JE, Walsh P. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J Am Acad Dermatol. 2003, 48:S56-7. 10.1067\/mjd.2003.116","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel B","year":"2019","unstructured":"Garel B, Ingen-Housz-Oro S, Afriat D, et al.. Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases. Br J Clin Pharmacol. 2019, 85:570-9. 10.1111\/bcp.13827","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40690","article-title":"Linear IgA bullous dermatosis attributable to the use of spironolactone: a case report","volume":"15","author":"Philip V","year":"2023","unstructured":"Philip V, Ogunleye OO, Chukwu N, Rosenblum I, Collins S. Linear IgA bullous dermatosis attributable to the use of spironolactone: a case report. Cureus. 2023, 15:e40690. 10.7759\/cureus.40690","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1521697","article-title":"Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system","volume":"12","author":"Yang Y","year":"2025","unstructured":"Yang Y, Xie H, Liu S, Jia Y, Cui B, Xiao Z. Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system. Front Med (Lausanne). 2025, 12:1521697. 10.3389\/fmed.2025.1521697","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5070\/d3245040155","article-title":"Diffuse vesiculobullous eruption with systemic findings","volume":"24","author":"Helmandollar KJ","year":"2018","unstructured":"Helmandollar KJ, Hoverson KR, Falkner RC, Meyerle JH. Diffuse vesiculobullous eruption with systemic findings. Dermatol Online J. 2018, 24:10.5070\/d3245040155","journal-title":"Dermatol Online J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(02)01422-5","article-title":"Linear IgA bullous dermatosis induced by angiotensin receptor antagonists","volume":"114","author":"Pe\u00f1a-Penabad C","year":"2003","unstructured":"Pe\u00f1a-Penabad C, Rodr\u0131\u0301guez-Lozano J, del Pozo J, Garc\u0131\u0301a-Silva J, Fonseca E. Linear IgA bullous dermatosis induced by angiotensin receptor antagonists. Am J Med. 2003, 114:163-4. 10.1016\/s0002-9343(02)01422-5","journal-title":"Am J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal J","year":"2013","unstructured":"Chanal J, Ingen-Housz-Oro S, Ortonne N, et al.. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol. 2013, 169:1041-8. 10.1111\/bjd.12488","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.3315\/jdcr.2012.1119","article-title":"Drug-induced linear IgA bullous dermatosis after discontinuation of cefuroxime axetil treatment","volume":"6","author":"Pastuszczak M","year":"2012","unstructured":"Pastuszczak M, Lipko-Godlewska S, Jaworek AK, Wojas-Pelc A. Drug-induced linear IgA bullous dermatosis after discontinuation of cefuroxime axetil treatment. J Dermatol Case Rep. 2012, 6:117-9.","journal-title":"J Dermatol Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2024.03.015","article-title":"Linear IgA bullous dermatosis: 32 years of experience","volume":"100","author":"Atci T","year":"2025","unstructured":"Atci T, Pehlivan Ulutas G, G\u00fcreler Sirkeci E, K\u00fc\u00e7\u00fcko\u011flu R. Linear IgA bullous dermatosis: 32 years of experience. An Bras Dermatol. 2025, 100:277-82. 10.1016\/j.abd.2024.03.015","journal-title":"An Bras Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17041","article-title":"Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review","volume":"63","author":"Wang KL","year":"2024","unstructured":"Wang KL, Lehman JS, Todd A, Davis DM. Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review. Int J Dermatol. 2024, 63:936-41. 10.1111\/ijd.17041","journal-title":"Int J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441981-linear-iga-bullous-dermatosis-in-an-elderly-patient-following-meloxicam-and-candesartan-use-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:21:03Z","timestamp":1765556463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441981-linear-iga-bullous-dermatosis-in-an-elderly-patient-following-meloxicam-and-candesartan-use-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.99054","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}